Hang Hubert Yin

Hang Hubert Yin stands as a leading figure in chemical biology and pharmaceutical sciences at Tsinghua University, where he serves as Professor and Deputy Dean of the School of Pharmaceutical Sciences. After completing his undergraduate studies at Peking University and earning his PhD from Yale University in 2004, he conducted postdoctoral research at the University of Pennsylvania School of Medicine before establishing his independent career at the University of Colorado Boulder. His groundbreaking research at the intersection of chemistry, biology, and engineering has led to significant advances in drug development, particularly in addressing opioid-related challenges and Parkinson's disease treatment. His team's discovery that morphine causes inflammation through binding to lymphocyte antigen 96 and subsequent TLR4 activation has opened new pathways for improved pain management therapies. His scientific impact is evidenced through numerous prestigious recognitions, including the American Chemical Society David W. Robertson Award, NSF CAREER Award, and the AACR Gertrude B. Elion Cancer Research Award. Through his leadership at Tsinghua's School of Pharmaceutical Sciences, Yin continues to advance the frontiers of structure-based drug design, membrane protein research, and biotechnology development, while mentoring the next generation of pharmaceutical scientists.